Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
Open Access
- 1 December 2020
- journal article
- letter
- Published by Elsevier in Thrombosis Research
- Vol. 196, 268-271
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pulmonary Arterial Thrombosis in COVID-19 With Fatal OutcomeAnnals of Internal Medicine, 2020
- Targeting the immunology of coronavirus disease-19: synchronization creates symphonyRheumatology International, 2020
- Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19)Platelets, 2020
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin SystemCirculation Research, 2020
- Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New ChallengeThrombosis and Haemostasis, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxisMedicine, 2019
- Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxisThe American Journal of Surgery, 2017
- Evaluation of aspirin response by Multiplate® whole blood aggregometry and light transmission aggregometryPlatelets, 2009